DAS
BXRX

Dynamic Advisor Solutions’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Dynamic Advisor Solutions’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-275
Closed -$3K – 763
2022
Q3 		$3K Buy
+275
New +$6.4K ﹤0.01% 685
2021
Q1 		– Sell
-8
Closed -$12K – 797
2020
Q4 		$12K Buy
+8
New +$16.4K ﹤0.01% 656

Other funds holding BXRX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SN
Sittner & Nelson Eugene, Oregon $274M AUM 22.46% 1-Year Est. Return

Dynamic Advisor Solutions's BXRX Position: Q4 2022 in Review

Dynamic Advisor Solutions sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q4 2022, closing a stake of 275 shares — an estimated $3K sold.

Dynamic Advisor Solutions first reported a position in BXRX in Q4 2020 and held it in 2 quarters. The position peaked at $12K in Q4 2020. 10 funds tracked by Wall St. Rank hold BXRX as of Q4 2022.

  • Dynamic Advisor Solutions reported no remaining Baudax Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Dynamic Advisor Solutions sold 275 Baudax Bio, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Dynamic Advisor Solutions first reported a position in Baudax Bio, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Dynamic Advisor Solutions's Baudax Bio, Inc. Common Stock position peaked at $12K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q4 2022.

Based on Dynamic Advisor Solutions's 13F filing for Q4 2022, filed 13 Jan 2023.